Tissue Regenix Group (LSE:TRX) Pretax Margin %: -7.38% (As of Jun. 2025)


What is Tissue Regenix Group Pretax Margin %?

Tissue Regenix Group LSE:TRX Pretax Margin % is -7.38% as of Jun. 2025. The stock has 5 warning signs investors should review.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Tissue Regenix Group's Pre-Tax Income for the six months ended in Jun. 2025 was £-0.75 Mil. Tissue Regenix Group's Revenue for the six months ended in Jun. 2025 was £10.17 Mil. Therefore, Tissue Regenix Group's pretax margin for the quarter that ended in Jun. 2025 was -7.38%.

The historical rank and industry rank for Tissue Regenix Group's Pretax Margin % or its related term are showing as below:

LSE:TRX' s Pretax Margin % Range Over the Past 10 Years
Min: -8183.85   Med: -67.61   Max: -1.97
Current: -5.38

LSE:TRX's Pretax Margin % is not ranked
in the Biotechnology industry.
Industry Median: -90.37 vs LSE:TRX: -5.38

Tissue Regenix Group  (LSE:TRX) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Tissue Regenix Group Pretax Margin % Related Terms

Tissue Regenix Group Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Tissue Regenix Group's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tissue Regenix Group Pretax Margin % Chart

Tissue Regenix Group Annual Data
Trend Jan15 Jan16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -79.82 -26.04 -11.56 -7.18 -1.97

Tissue Regenix Group Semi-Annual Data
Jul15 Jan16 Jul16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.54 -7.92 -0.43 -3.59 -7.38

LSE:TRX vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Tissue Regenix Group's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tissue Regenix Group Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Tissue Regenix Group's Pretax Margin % falls into.


Tissue Regenix Group Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Tissue Regenix Group's Pretax Margin for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-0.446/22.659
=-1.97 %

Tissue Regenix Group's Pretax Margin for the quarter that ended in Jun. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-0.75/10.168
=-7.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -7.38% mean?
Tissue Regenix Group (LSE:TRX) has a Pretax Margin % of -7.38% as of Jun. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Tissue Regenix Group and its competitors.
Is Tissue Regenix Group's Pretax Margin % too high?
Tissue Regenix Group's current Pretax Margin % is -7.38%.
How does Tissue Regenix Group's Pretax Margin % compare to VRTX and REGN?
Tissue Regenix Group's Pretax Margin % of -7.38% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Tissue Regenix Group and its competitors. Tissue Regenix Group's current Pretax Margin % is -7.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tissue Regenix Group stock overvalued right now?
Tissue Regenix Group (LSE:TRX) has a current Pretax Margin % of -7.38%. The stock's GF Value™ is £0.87, compared to a current price of £0.07 — trading 91.7% below its estimated fair value. The current Pretax Margin % is -7.38%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Tissue Regenix Group (LSE:TRX), the current Pretax Margin % is -7.38% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tissue Regenix Group Business Description

Address Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.